2019 Schedule & Agenda

BIO Asia Webinar Series
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO Asia Webinar Series
Jump to Day
10 Results
Tuesday, March 5
10:30 AM - 10:45 AM (JST)
NBHL has expertise in generating of functional mAbs targeting multispanning membrane protein such…
11:30 AM - 11:45 AM (JST)
TAGCyx provides unique DNA aptamer with proprietary artificial nucleic acid base. Aptamer is an…
1:45 PM - 2:00 PM (JST)
VORONOI primarily develops small molecule inhibitors of kinases using kinase profiling and…
Wednesday, March 6
8:30 AM - 8:45 AM (JST)
AIMM is a preclinical stage company in the process of advancing 2 antibodies into the clinic.
8:45 AM - 9:00 AM (JST)
Kleo Pharmaceuticals is a unique immuno-oncology company developing next-generation bispecific…
9:00 AM - 9:15 AM (JST)
Developing an allogeneic regenerative medicinal product for severe heart failure, which is made…
10:30 AM - 10:45 AM (JST)
HanaVax is developing vaccines administered by small painless sprays into the nose. Our…
10:45 AM - 11:00 AM (JST)
M Bio Thechnology is a world leading company focused on the discovery and development of innovative…
2:45 PM - 3:00 PM (JST)
Aspect Biosystems Ltd. is a privately held biotechnology company operating at the leading edge of…
3:00 PM - 3:15 PM (JST)
GEXVal Inc. is a Japanese-based spinoff company from Takeda Pharmaceutical Company Limited,…